.
.
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.
.
...select portfolio and asset combination for display on market band
.but shocking figures uncovered by labour yesterday show some patients are suffering agonising waits of as many as 541 days to begin treatment..
.elizabeth loder, md, professor of neurology, harvard medical school; chief, division of headache, brigham & women's hospital.